Next Article in Journal / Special Issue
Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases
Previous Article in Journal
Degree of Conversion and Oxygen-Inhibited Layer Effect of Three Dental Adhesives
Previous Article in Special Issue
Impact of Soft Tissue Pathophysiology in the Development and Maintenance of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)
Review

Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw

Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China
Academic Editor: Christian Walter
Dent. J. 2016, 4(4), 38; https://doi.org/10.3390/dj4040038
Received: 11 October 2016 / Revised: 11 October 2016 / Accepted: 21 October 2016 / Published: 28 October 2016
(This article belongs to the Special Issue New Cancer and Osteoporosis Therapies and Osteocrosis of the Jaws)
Medication-related osteonecrosis of the jaw (MRONJ) was first reported more than a decade ago. Since then, numerous cases have been diagnosed. Currently, there are three groups of drugs related to MRONJ: bisphosphonates, denosumab and anti-angiogenic drugs. As MRONJ can lead to debilitating clinical sequels and limited effective treatment options are available, much research has been done in understanding its pathophysiology. Until now, the exact pathogenesis of MRONJ has not been fully elucidated. While history of invasive dental procedures or local trauma may be present, some cases occur spontaneously without any preceding factors. This review aims to examine and discuss the three main hypotheses for the pathogenesis of MRONJ, namely suppressed bone turnover, cellular toxicity and infection. View Full-Text
Keywords: osteonecrosis of the jaw; BRONJ; MRONJ; DRONJ; bisphosphonate; zoledronate; denosumab; anti-angiogenic osteonecrosis of the jaw; BRONJ; MRONJ; DRONJ; bisphosphonate; zoledronate; denosumab; anti-angiogenic
Show Figures

Figure 1

MDPI and ACS Style

Wat, W.Z.M. Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw. Dent. J. 2016, 4, 38. https://doi.org/10.3390/dj4040038

AMA Style

Wat WZM. Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw. Dentistry Journal. 2016; 4(4):38. https://doi.org/10.3390/dj4040038

Chicago/Turabian Style

Wat, Winnie Z.M. 2016. "Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw" Dentistry Journal 4, no. 4: 38. https://doi.org/10.3390/dj4040038

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop